Zomedica Corp. (NYSEAMERICAN:ZOM – Get Free Report) Director Johnny D. Powers purchased 100,000 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was bought at an average cost of $0.12 per share, with a total value of $12,000.00. Following the completion of the purchase, the director now owns 2,425,000 shares of the company’s stock, valued at approximately $291,000. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Zomedica Price Performance
Shares of ZOM opened at $0.15 on Thursday. Zomedica Corp. has a 52 week low of $0.12 and a 52 week high of $0.23.
Institutional Investors Weigh In On Zomedica
A hedge fund recently raised its stake in Zomedica stock. Virtu Financial LLC lifted its position in shares of Zomedica Corp. (NYSEAMERICAN:ZOM – Free Report) by 1,585.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 168,773 shares of the company’s stock after purchasing an additional 158,757 shares during the period. Virtu Financial LLC’s holdings in Zomedica were worth $25,000 at the end of the most recent quarter. Institutional investors and hedge funds own 8.95% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Research Report on Zomedica
About Zomedica
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
See Also
- Five stocks we like better than Zomedica
- 3 Warren Buffett Stocks to Buy Now
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
- Investing in the High PE Growth Stocks
- Unusual Trading Volume in Gerdau: A Signal for Buyers?
- Consumer Staples Stocks, Explained
- 3 Stocks Gaining Traction in Their Turnaround Stories
Receive News & Ratings for Zomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica and related companies with MarketBeat.com's FREE daily email newsletter.